Cargando…

Discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors

Bisphenol A (BPA) is used as an industrial raw material for polycarbonate plastics and epoxy resins; however, various concerns have been reported regarding its status as an endocrine-disrupting chemical. BPA interacts not only with oestrogen receptors (ERs) but constitutive androstane receptor, preg...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuya, Takahiro, Iwamoto, Masaki, Liu, Xiaohui, Matsushima, Ayami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616570/
https://www.ncbi.nlm.nih.gov/pubmed/31289329
http://dx.doi.org/10.1038/s41598-019-46272-y
_version_ 1783433536130252800
author Masuya, Takahiro
Iwamoto, Masaki
Liu, Xiaohui
Matsushima, Ayami
author_facet Masuya, Takahiro
Iwamoto, Masaki
Liu, Xiaohui
Matsushima, Ayami
author_sort Masuya, Takahiro
collection PubMed
description Bisphenol A (BPA) is used as an industrial raw material for polycarbonate plastics and epoxy resins; however, various concerns have been reported regarding its status as an endocrine-disrupting chemical. BPA interacts not only with oestrogen receptors (ERs) but constitutive androstane receptor, pregnane X receptor, and oestrogen-related receptor γ (ERRγ); therefore, the bisphenol structure represents a privileged structure for the nuclear-receptor superfamily. Here, we screen 127 BPA-related compounds by competitive-binding assay using [(3)H]oestradiol and find that 20 compounds bind to ERα with high affinity. We confirm most of these as ERα agonists; however, four compounds, including bisphenol M and bisphenol P act as novel antagonists. These structures harbour three benzene rings in tandem with terminal hydroxy groups at para-positions, with this tandem tri-ring bisphenol structure representing a novel privileged structure for an ERα antagonist. Additionally, we perform an ab initio calculation and develop a new clipping method for halogen bonding or non-covalent interaction using DV-Xα evaluation for biomolecules.
format Online
Article
Text
id pubmed-6616570
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-66165702019-07-18 Discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors Masuya, Takahiro Iwamoto, Masaki Liu, Xiaohui Matsushima, Ayami Sci Rep Article Bisphenol A (BPA) is used as an industrial raw material for polycarbonate plastics and epoxy resins; however, various concerns have been reported regarding its status as an endocrine-disrupting chemical. BPA interacts not only with oestrogen receptors (ERs) but constitutive androstane receptor, pregnane X receptor, and oestrogen-related receptor γ (ERRγ); therefore, the bisphenol structure represents a privileged structure for the nuclear-receptor superfamily. Here, we screen 127 BPA-related compounds by competitive-binding assay using [(3)H]oestradiol and find that 20 compounds bind to ERα with high affinity. We confirm most of these as ERα agonists; however, four compounds, including bisphenol M and bisphenol P act as novel antagonists. These structures harbour three benzene rings in tandem with terminal hydroxy groups at para-positions, with this tandem tri-ring bisphenol structure representing a novel privileged structure for an ERα antagonist. Additionally, we perform an ab initio calculation and develop a new clipping method for halogen bonding or non-covalent interaction using DV-Xα evaluation for biomolecules. Nature Publishing Group UK 2019-07-09 /pmc/articles/PMC6616570/ /pubmed/31289329 http://dx.doi.org/10.1038/s41598-019-46272-y Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Masuya, Takahiro
Iwamoto, Masaki
Liu, Xiaohui
Matsushima, Ayami
Discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors
title Discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors
title_full Discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors
title_fullStr Discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors
title_full_unstemmed Discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors
title_short Discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors
title_sort discovery of novel oestrogen receptor α agonists and antagonists by screening a revisited privileged structure moiety for nuclear receptors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616570/
https://www.ncbi.nlm.nih.gov/pubmed/31289329
http://dx.doi.org/10.1038/s41598-019-46272-y
work_keys_str_mv AT masuyatakahiro discoveryofnoveloestrogenreceptoraagonistsandantagonistsbyscreeningarevisitedprivilegedstructuremoietyfornuclearreceptors
AT iwamotomasaki discoveryofnoveloestrogenreceptoraagonistsandantagonistsbyscreeningarevisitedprivilegedstructuremoietyfornuclearreceptors
AT liuxiaohui discoveryofnoveloestrogenreceptoraagonistsandantagonistsbyscreeningarevisitedprivilegedstructuremoietyfornuclearreceptors
AT matsushimaayami discoveryofnoveloestrogenreceptoraagonistsandantagonistsbyscreeningarevisitedprivilegedstructuremoietyfornuclearreceptors